Target Price | $90.65 |
Price | $84.29 |
Potential | 7.55% |
Number of Estimates | 26 |
26 Analysts have issued a price target Lam Research 2026 . The average Lam Research target price is $90.65. This is 7.55% higher than the current stock price. The highest price target is $125.00 48.30% , the lowest is $70.00 16.95% . | |
A rating was issued by 33 analysts: 26 Analysts recommend Lam Research to buy, 7 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Lam Research stock has an average upside potential 2026 of 7.55% . Most analysts recommend the Lam Research stock at Purchase. |
26 Analysts have issued a sales forecast Lam Research 2025 . The average Lam Research sales estimate is $18.2b . This is 6.50% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $18.3b 6.94% , the lowest is $18.1b 5.39% .
This results in the following potential growth metrics:
2024 | $14.9b | 14.48% |
---|---|---|
2025 | $18.2b | 22.43% |
2026 | $18.7b | 2.51% |
2027 | $20.7b | 10.90% |
2028 | $23.3b | 12.46% |
2029 | $24.6b | 5.57% |
15 Analysts have issued an Lam Research EBITDA forecast 2025. The average Lam Research EBITDA estimate is $6.2b . This is 9.37% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $6.3b 11.11% , the lowest is $5.8b 3.12% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $4.7b | 16.89% |
---|---|---|
2025 | $6.2b | 32.29% |
2026 | $6.2b | 0.06% |
2027 | $7.1b | 13.97% |
2028 | $8.3b | 17.70% |
2029 | $8.9b | 6.96% |
2024 | 31.43% | 2.83% |
---|---|---|
2025 | 33.96% | 8.04% |
2026 | 33.11% | 2.50% |
2027 | 34.03% | 2.78% |
2028 | 35.61% | 4.64% |
2029 | 36.08% | 1.32% |
19 Lam Research Analysts have issued a net profit forecast 2025. The average Lam Research net profit estimate is $5.1b . This is 11.09% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $5.2b 12.19% , the lowest is $4.7b 0.83% .
This results in the following potential growth metrics and future Net Margins:
2024 | $3.7b | 12.65% |
---|---|---|
2025 | $5.1b | 37.52% |
2026 | $5.1b | 1.20% |
2027 | $6.0b | 17.93% |
2028 | $6.6b | 11.48% |
2029 | $8.0b | 21.04% |
2024 | 24.96% | 2.14% |
---|---|---|
2025 | 28.04% | 12.33% |
2026 | 27.02% | 3.64% |
2027 | 28.73% | 6.33% |
2028 | 28.48% | 0.87% |
2029 | 32.66% | 14.68% |
19 Analysts have issued a Lam Research forecast for earnings per share. The average Lam Research EPS is $3.99 . This is 11.14% higher than earnings per share in the financial year 2024. The highest EPS forecast is $4.05 12.19% , the lowest is $3.64 0.83% .
This results in the following potential growth metrics and future valuations:
2024 | $2.90 | 12.65% |
---|---|---|
2025 | $3.99 | 37.59% |
2026 | $3.94 | 1.25% |
2027 | $4.65 | 18.02% |
2028 | $5.18 | 11.40% |
2029 | $6.27 | 21.04% |
Current | 23.48 | 29.99% |
---|---|---|
2025 | 21.13 | 10.01% |
2026 | 21.39 | 1.23% |
2027 | 18.14 | 15.19% |
2028 | 16.27 | 10.31% |
2029 | 13.44 | 17.39% |
Based on analysts' sales estimates for 2025, the Lam Research stock is valued at an EV/Sales of 5.86 and an P/S ratio of 5.91 .
This results in the following potential growth metrics and future valuations:
Current | 6.24 | 25.00% |
---|---|---|
2025 | 5.86 | 6.17% |
2026 | 5.71 | 2.45% |
2027 | 5.15 | 9.83% |
2028 | 4.58 | 11.08% |
2029 | 4.34 | 5.28% |
Current | 6.29 | 24.86% |
---|---|---|
2025 | 5.91 | 6.10% |
2026 | 5.76 | 2.45% |
2027 | 5.20 | 9.83% |
2028 | 4.62 | 11.08% |
2029 | 4.38 | 5.28% |
Analyst | Rating | Action | Date |
---|---|---|---|
Cantor Fitzgerald |
Overweight
➜
Overweight
|
Unchanged | Apr 24 2025 |
Wells Fargo |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Apr 24 2025 |
Evercore ISI Group |
Outperform
➜
Outperform
|
Unchanged | Apr 24 2025 |
Morgan Stanley |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Apr 24 2025 |
TD Securities |
Buy
➜
Buy
|
Unchanged | Apr 24 2025 |
Needham |
Buy
➜
Buy
|
Unchanged | Apr 24 2025 |
Barclays |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Apr 22 2025 |
Analyst Rating | Date |
---|---|
Unchanged
Cantor Fitzgerald:
Overweight
➜
Overweight
|
Apr 24 2025 |
Unchanged
Wells Fargo:
Equal-Weight
➜
Equal-Weight
|
Apr 24 2025 |
Unchanged
Evercore ISI Group:
Outperform
➜
Outperform
|
Apr 24 2025 |
Unchanged
Morgan Stanley:
Equal-Weight
➜
Equal-Weight
|
Apr 24 2025 |
Unchanged
TD Securities:
Buy
➜
Buy
|
Apr 24 2025 |
Unchanged
Needham:
Buy
➜
Buy
|
Apr 24 2025 |
Unchanged
Barclays:
Equal-Weight
➜
Equal-Weight
|
Apr 22 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.